Dashboard
Manage Tickers

BCDABioCardia, Inc.

Nasdaq biocardia.com


$ 4.63 $ -0.58 (-11.15 %)    

Friday, 31-May-2024 15:41:47 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 454.82 $ -0.84 (-0.19 %)
DIA $ 398.57 $ 6.05 (1.59 %)
SPY $ 530.36 $ 4.76 (0.91 %)
TLT $ 91.26 $ 0.61 (0.68 %)
GLD $ 225.37 $ -1.27 (-0.59 %)
$ 4.62
$ 5.12
$ 0.00 x 0
$ 0.00 x 0
$ 4.63 - $ 5.12
$ 4.35 - $ 43.80
48,259
na
8.41M
$ 0.32
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-14-2024 03-31-2024 10-Q
2 03-27-2024 12-31-2023 10-K
3 11-08-2023 09-30-2023 10-Q
4 08-09-2023 06-30-2023 10-Q
5 05-10-2023 03-31-2023 10-Q
6 03-29-2023 12-31-2022 10-K
7 11-09-2022 09-30-2022 10-Q
8 08-10-2022 06-30-2022 10-Q
9 05-11-2022 03-31-2022 10-Q
10 03-29-2022 12-31-2021 10-K
11 11-10-2021 09-30-2021 10-Q
12 08-12-2021 06-30-2021 10-Q
13 05-13-2021 03-31-2021 10-Q
14 03-30-2021 12-31-2020 10-K
15 11-10-2020 09-30-2020 10-Q
16 08-13-2020 06-30-2020 10-Q
17 05-15-2020 03-31-2020 10-Q
18 04-09-2020 12-31-2019 10-K
19 11-19-2019 09-30-2019 10-Q
20 08-14-2019 06-30-2019 10-Q
21 05-15-2019 03-31-2019 10-Q
22 04-02-2019 12-31-2018 10-K
23 11-08-2018 09-30-2018 10-Q
24 08-09-2018 06-30-2018 10-Q
25 05-10-2018 03-31-2018 10-Q
26 03-16-2018 12-31-2017 10-K
27 11-09-2017 09-30-2017 10-Q
28 08-14-2017 06-30-2017 10-Q
29 05-11-2017 03-31-2017 10-Q
30 03-30-2017 12-31-2016 10-K
31 10-17-2016 09-30-2016 10-Q
32 08-02-2016 06-30-2016 10-Q
33 05-03-2016 03-31-2016 10-Q
34 03-25-2016 12-31-2015 10-K
35 10-29-2015 09-30-2015 10-Q
36 08-12-2015 06-30-2015 10-Q
37 05-12-2015 03-31-2015 10-Q
38 03-24-2015 12-31-2014 10-K
39 11-06-2014 09-30-2014 10-Q
40 08-06-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

biocardia-shares-resume-trade
BioCardia Shares Resume Trade
05/30/2024 13:00:59

trading-halt-halt-status-updated-at-85500-am-et-quotation-resumption-news-and-resumption-times
Trading Halt: Halt status updated at 8:55:...
05/30/2024 12:55:04

trading-halt-halted-at-75000-pm-et---trading-halt-halt-news-pending
Trading Halt: Halted at 7:50:00 p.m. ET - ...
05/29/2024 23:50:04

hc-wainwright--co-reiterates-buy-on-biocardia-maintains-4-price-target
HC Wainwright & Co. Reiterates Buy on BioC...
05/29/2024 17:29:57

HC Wainwright & Co. analyst Joseph Pantginis reiterates BioCardia (NASDAQ:BCDA) with a Buy and maintains $4 price target.

biocardia-intends-to-effect-reverse-stock-split-of-its-common-stock-at-ratio-of-1-post-split-share-for-every-15-pre-split-shares
BioCardia Intends To Effect Reverse Stock ...
05/21/2024 21:02:59

The reverse stock split will become effective at 12:01 a.m. Eastern Daylight Time on Thursday, May 30, 2024.

biocardia-q1-eps-009-up-from-017-yoy-sales-5500k-down-from-6400k-yoy
BioCardia Q1 EPS $(0.09) Up From $(0.17) Y...
05/14/2024 20:07:45

BioCardia (NASDAQ:BCDA) reported quarterly losses of $(0.09) per share. This is a 47.06 percent increase over losses of $(0.17)...

biocardia-announced-the-primary-endpoint-results-of-the-open-label-roll-in-cohort-of-the-cardiamp-cell-therapy-in-chronic-myocardial-ischemia-trial
BioCardia Announced The Primary Endpoint R...
05/01/2024 11:16:29

biocardia-announces-results-from-open-label-roll-in-cohort-of-patients-having-chronic-myocardial-ischemia-with-refractory-angina-showed-avg-increase-in-exercise-tolerance-of-107-seconds-and-an-avg--of-82-reduction-in-angina-episodes-at-the-primary-six-month-follow-up-endpoint
BioCardia Announces Results From Open Labe...
05/01/2024 11:15:51

biocardia-completes-enrollment-of-cardiamp-cell-therapy-for-treatment-of-chronic-myocardial-ischemia-trial-open-label-roll-in-cohort
BioCardia Completes Enrollment Of CardiAMP...
04/25/2024 13:01:43

expensify-and-2-other-stocks-under-2-insiders-are-buying
Expensify And 2 Other Stocks Under $2 Insi...
04/22/2024 11:38:09

12-health-care-stocks-moving-in-fridays-pre-market-session
12 Health Care Stocks Moving In Friday's P...
03/29/2024 12:06:18

biocardia-q4-earnings-insights
BioCardia: Q4 Earnings Insights
03/27/2024 20:10:06

biocardia-q4-eps-009-beats-011-estimate-sales-1300k-miss-9000k-estimate
BioCardia Q4 EPS $(0.09) Beats $(0.11) Est...
03/27/2024 20:06:29

BioCardia (NASDAQ:BCDA) reported quarterly losses of $(0.09) per share which beat the analyst consensus estimate of $(0.11) by ...

biocardia-ended-2023-with-cash-and-cash-equivalents-of-11m
BioCardia Ended 2023 With Cash And Cash Eq...
03/27/2024 18:04:36

https://www.biocardia.com/investors/press-releases/id/1037?pressReleaseId=187

earnings-scheduled-for-march-27-2024
Earnings Scheduled For March 27, 2024
03/27/2024 09:02:44

Companies Reporting Before The Bell • Local Bounti (NYSE:LOCL) is projected to report quarterly loss at $2.41 per share on rev...

preview-biocardias-earnings
Preview: BioCardia's Earnings
03/26/2024 16:01:35

biocardia-announced-a-long-term-partnership-to-advance-stemcardias-investigational-pluripotent-stem-cell-product-candidate-for-the-treatment-of-heart-failure
BioCardia Announced A Long-term Partnershi...
03/13/2024 11:14:11

Under the partnership, BioCardia is the exclusive biotherapeutic delivery partner for StemCardia's cell therapy candidate t...

biocardia-shares-are-trading-higher-after-the-company-announced-cms-approval-of-reimbursement-coverage-of-the-cardiamp-cell-therapy-phase-iii-heart-failure-study
BioCardia shares are trading higher after ...
03/12/2024 11:06:52

biocardia-announces-cms-approval-of-coverage-of-the-cardiamp-cell-therapy-confirmatory-phase-iii-heart-failure-study
BioCardia Announces CMS Approval Of Covera...
03/12/2024 11:04:30

crude-oil-down-over-1-quoin-pharmaceuticals-shares-spike-higher
Crude Oil Down Over 1%; Quoin Pharmaceutic...
03/04/2024 19:34:26

U.S. stocks traded lower toward the end of trading, with the S&P 500 edging lower on Monday. The Dow traded down 0.20% to ...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION